Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Matrix metalloproteinase 20 (MMP20), also known as enamelysin, is a member of the matrix metalloproteinase family and is essential for normal tooth development. It primarily functions to cleave proteins like amelogenin and ameloblastin during enamel formation. Mutations in the MMP20 gene cause amelogenesis imperfecta.
Inhibition of enzymatic activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Matrix Metalloproteinase 20 (MMP20).